Keywords: Novartis, USA, Illegal marketing, Alcon merger, Legal position, Trileptal, Diovan

Novartis in $422.5 million settlement over US illegal marketing; cites Swiss law expert on Alcon IDC’s legal position in proposed merger

Article | 01 October 2010

Print This

Swiss drug major Novartis (NOVN: VX) says its US subsidiary, Novartis Pharmaceuticals Corp (NPC), has reached a global resolution with ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in